Praveen Rastogi, MD, FCCP, ABSM | |
915 Eagles Landing Pkwy, Stockbridge, GA 30281-5011 | |
(770) 996-6699 | |
(770) 997-4790 |
Full Name | Praveen Rastogi |
---|---|
Gender | Male |
Speciality | Critical Care (intensivists) |
Experience | 48 Years |
Location | 915 Eagles Landing Pkwy, Stockbridge, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265406375 | NPI | - | NPPES |
002866668A | Medicaid | GA |
Facility Name | Location | Facility Type |
---|---|---|
Piedmont Henry Hospital | Stockbridge, GA | Hospital |
Piedmont Fayette Hospital | Fayetteville, GA | Hospital |
Northside Hospital | Atlanta, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Pulmonary Medicine Associates | 9931013760 | 5 |
News Archive
Pain Therapeutics, Inc. announced today the completion of a special, one-time nondividend cash distribution of $2.00 per share, or an aggregate of about $86 million. In connection with this event, Nasdaq® will adjust the price of PTIE by $2.00 per share at today's open.
Babies that are delivered by caeserean section are more likely to become overweight or obese as adults, according to researchers from Imperial College, London.
Today, the Damon Runyon Cancer Research Foundation held the fourth annual Accelerating Cancer Cures Research Symposium. The yearly meeting is designed to encourage collaboration between cancer researchers in industry and their counterparts in academia in order to overcome many of the issues that currently impede progress against cancer.
For the first time, scientists have succeeded in coaxing laboratory cultures of human stem cells to develop into the specialized, unique cells needed to repair a patient's defective or diseased bladder.
› Verified 7 days ago
Entity Name | Pulmonary Medicine Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1720009244 PECOS PAC ID: 9931013760 Enrollment ID: O20031117000455 |
News Archive
Pain Therapeutics, Inc. announced today the completion of a special, one-time nondividend cash distribution of $2.00 per share, or an aggregate of about $86 million. In connection with this event, Nasdaq® will adjust the price of PTIE by $2.00 per share at today's open.
Babies that are delivered by caeserean section are more likely to become overweight or obese as adults, according to researchers from Imperial College, London.
Today, the Damon Runyon Cancer Research Foundation held the fourth annual Accelerating Cancer Cures Research Symposium. The yearly meeting is designed to encourage collaboration between cancer researchers in industry and their counterparts in academia in order to overcome many of the issues that currently impede progress against cancer.
For the first time, scientists have succeeded in coaxing laboratory cultures of human stem cells to develop into the specialized, unique cells needed to repair a patient's defective or diseased bladder.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Praveen Rastogi, MD, FCCP, ABSM 915 Eagles Landing Pkwy, Stockbridge, GA 30281-5011 Ph: (770) 996-6699 | Praveen Rastogi, MD, FCCP, ABSM 915 Eagles Landing Pkwy, Stockbridge, GA 30281-5011 Ph: (770) 996-6699 |
News Archive
Pain Therapeutics, Inc. announced today the completion of a special, one-time nondividend cash distribution of $2.00 per share, or an aggregate of about $86 million. In connection with this event, Nasdaq® will adjust the price of PTIE by $2.00 per share at today's open.
Babies that are delivered by caeserean section are more likely to become overweight or obese as adults, according to researchers from Imperial College, London.
Today, the Damon Runyon Cancer Research Foundation held the fourth annual Accelerating Cancer Cures Research Symposium. The yearly meeting is designed to encourage collaboration between cancer researchers in industry and their counterparts in academia in order to overcome many of the issues that currently impede progress against cancer.
For the first time, scientists have succeeded in coaxing laboratory cultures of human stem cells to develop into the specialized, unique cells needed to repair a patient's defective or diseased bladder.
› Verified 7 days ago